Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-6148
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits ; volume:16 ; number:1 ; day:11 ; month:11 ; year:2020 ; pages:1-10 ; date:12.2020
BMC veterinary research ; 16, Heft 1 (11.11.2020), 1-10, 12.2020
- Creator
-
Askar, Raad
Fredriksson, Elin
Manell, Elin
Hedeland, Mikael
Bondesson, Ulf
Bate, Simon
Olsén, Lena
Hedenqvist, Patricia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12917-020-02618-7
- URN
-
urn:nbn:de:101:1-2020122219121291081948
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Askar, Raad
- Fredriksson, Elin
- Manell, Elin
- Hedeland, Mikael
- Bondesson, Ulf
- Bate, Simon
- Olsén, Lena
- Hedenqvist, Patricia
- SpringerLink (Online service)
Other Objects (12)
Correction to: Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits
Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Bioavailability of IgG Administered by the Subcutaneous Route
Structural changes in femoral bone microstructure of female rabbits after intramuscular administration of quercetin
Gene expression identifies metabolic and functional differences between intramuscular and subcutaneous adipocytes in cattle
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Effects of the FHL2 gene on the development of subcutaneous and intramuscular adipocytes in goats
Comprehensive transcriptomic view of the role of the LGALS12 gene in porcine subcutaneous and intramuscular adipocytes
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder
Rabbits
Correction to: Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits
Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Bioavailability of IgG Administered by the Subcutaneous Route
Structural changes in femoral bone microstructure of female rabbits after intramuscular administration of quercetin
Gene expression identifies metabolic and functional differences between intramuscular and subcutaneous adipocytes in cattle
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Effects of the FHL2 gene on the development of subcutaneous and intramuscular adipocytes in goats
Comprehensive transcriptomic view of the role of the LGALS12 gene in porcine subcutaneous and intramuscular adipocytes
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder
Rabbits
Correction to: Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits
Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial
Patients' perspectives on buprenorphine subcutaneous implant: a case series
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Bioavailability of IgG Administered by the Subcutaneous Route
Structural changes in femoral bone microstructure of female rabbits after intramuscular administration of quercetin
Gene expression identifies metabolic and functional differences between intramuscular and subcutaneous adipocytes in cattle
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Effects of the FHL2 gene on the development of subcutaneous and intramuscular adipocytes in goats
Comprehensive transcriptomic view of the role of the LGALS12 gene in porcine subcutaneous and intramuscular adipocytes
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder